what products does vineet laboratories make

The company produces API intermediates, bulk drugs, and fine chemicals, which are essential for the pharmaceutical industry, with operations based in Malkapur, Telangana.

what sector is vineet laboratories in

Vineet Laboratories operates in the pharmaceutical sector, specifically involved in the research, development, and manufacturing of pharmaceutical products.

when was vineet laboratories founded

Vineet Laboratories Limited was incorporated on December 10, 2016, though it began functioning as a manufacturing company in 2007 under its previous name, Ortin Laboratories.

who owns vineet laboratories

Vineet Laboratories is a publicly traded company registered at the Registrar of Companies, Hyderabad, and is owned by its shareholders, with no specific majority stake mentioned.

Vineet Laboratories Limited (VINEETLAB) Share Price Today — ₹36.1

Vineet Laboratories Limited (VINEETLAB) live stock price is ₹36.1 with a change of +3.03% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Vineet Laboratories Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Vineet Laboratories Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

VINEETLAB

NSEBSE

Vineet Laboratories Limited

Healthcare· Pharmaceuticals & Biotechnology· INE505Y01010· Scrip: 543298

EN हिन्दी ગુજરાતી मराठी

₹36.10

▲ 1.06 (+3.03%)

20/4/2026, 10:29:40 pm

NSE

₹36.10

▲ 1.06

+3.03%

BSE

₹39.27

▲ 3.00

+0.00%

244 trading days · 1Y period

TODAY 

Open35.04

High37.38

Low34.62

Prev Close35.04

Volume1.92Cr

Value₹0.3Cr

L: 34.62H: 37.38

52 WEEK

Low₹22.28

High₹42.01

70% of 52W range

Info

Face Value₹10

Listed2021-06-15

ISININE505Y01010

SeriesB

BSE Scrip543298

Key Metrics

1D

-2.20%

1W

-9.05%

1M

+28.27%

3M

+12.00%

6M

-8.45%

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales0.58

Mkt Cap₹57 Cr

Growth (QoQ)

Revenue-4.53%

PAT-212.12%

EPS-212.63%

Profitability

EBITDA Margin-27.9%

Net Margin-31.5%

TTM EBITDA M.-5.7%

TTM Net M.-7.9%

Dividend

Yield2.65%

Latest DPS₹1

Payout Ratio—

Growth—

TTM Revenue

₹98 Cr

TTM EBITDA

₹-6 Cr

TTM PAT

₹-8 Cr

TTM EPS

₹-8.39

Rev/Share

₹51.0

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	18 Cr	24 Cr	-5 Cr	-6 Cr	-6 Cr	₹-6.19
2024-09-30	19 Cr	21 Cr	-1 Cr	-2 Cr	-2 Cr	₹-1.98
2024-06-30	24 Cr	26 Cr	-2 Cr	-2 Cr	-2 Cr	₹-2.31
2024-03-31	37 Cr	36 Cr	2 Cr	1 Cr	2 Cr	₹2.09
2023-12-31	33 Cr	35 Cr	-2 Cr	-2 Cr	-2 Cr	₹-2.24
2023-09-30	43 Cr	41 Cr	3 Cr	3 Cr	2 Cr	₹2.62
2023-06-30	38 Cr	39 Cr	-1 Cr	-1 Cr	-1 Cr	₹-1.36
2023-03-31	57 Cr	52 Cr	5 Cr	5 Cr	4 Cr	₹3.85

Shareholding Pattern

CURRENT — 2026-03-31

Promoter6.0%

FII0.4%

Public94.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-12-23	Rights	Rights 13:12 @ Premium Rs 20/-
2024-09-17	Other	Annual General Meeting
2023-09-18	Other	Annual General Meeting
2022-09-19	Dividend	Dividend - Re 1 Per Share
2021-09-22	Other	Annual General Meeting

Price History

Date	Open	High	Low	Close	Volume
2026-04-30	39.60	39.60	36.63	38.06	49,789
2026-04-29	37.36	39.00	36.51	38.55	2.02L
2026-04-28	38.11	38.69	36.00	36.44	94,157
2026-04-27	43.50	43.50	36.71	38.07	7.08L
2026-04-24	41.45	43.38	41.37	42.45	2.55L
2026-04-23	39.99	42.55	39.00	41.45	2.18L
2026-04-22	39.21	40.69	38.51	39.99	1.40L
2026-04-21	37.50	43.45	36.48	39.21	4.70L
2026-04-20	35.04	37.38	34.62	36.21	2.60L
2026-04-17	32.58	35.38	31.50	35.04	1.90L
2026-04-16	32.49	32.94	31.70	32.80	46,504
2026-04-15	32.02	33.25	31.61	32.49	52,446
2026-04-13	32.02	32.83	31.67	32.03	67,861
2026-04-10	33.09	33.10	32.20	32.62	60,479
2026-04-09	32.01	33.35	32.01	33.09	68,633
2026-04-08	31.19	32.45	31.19	32.29	47,032
2026-04-07	30.02	31.50	30.02	31.19	74,485
2026-04-02	29.52	30.21	29.32	29.51	34,369
2026-04-01	31.60	31.60	28.66	29.47	91,068
2026-03-27	29.11	30.93	29.10	30.35	1.32L
2026-03-25	29.39	30.30	29.00	29.56	54,883
2026-03-24	29.53	30.25	28.61	29.39	76,004
2026-03-20	29.52	30.15	29.50	29.75	19,575
2026-03-19	29.52	30.24	29.45	29.86	78,914
2026-03-18	32.00	32.00	29.41	29.98	57,048
2026-03-17	29.84	30.90	28.80	29.01	1.25L
2026-03-16	29.39	30.49	29.39	29.84	56,370
2026-03-13	30.95	30.97	29.20	29.39	1.32L
2026-03-12	31.65	32.51	29.45	30.04	2.11L
2026-03-11	31.00	31.00	29.50	30.31	48,414

Frequently Asked Questions

About

Vineet Laboratories Limited is an Indian pharmaceutical company engaged in the research, development, manufacturing, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals. The company offers intermediates for various drugs including Lopinavir, Ritonavir, and Efavirenz, and is recognized as one of India's leading private sector enterprises in the pharmaceutical sector, established in 2016 and listed on both the BSE and NSE.

BOARD OF DIRECTORS

Kandula Mura

Whole-time Director

DEPARTED

Rcgd

Independent Director

DEPARTED

Dilip Vishnu Acharekar

Premananda Reddy Vennapusa

Rajesh Kumar Kathulla

Rameshkumar Bandari

Salish Pandurang Samant Executive Director

DEPARTED